Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Abivax (ABVX) Revenue: 2022-2025

Historic Revenue for Abivax (ABVX) over the last 1 years, with Jun 2025 value amounting to -$7.3 million.

  • Abivax's Revenue fell 21899.29% to -$7.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$13.0 million, marking a year-over-year decrease of 164.16%. This contributed to the annual value of $13.3 million for FY2024, which is 167.56% up from last year.
  • As of Q2 2025, Abivax's Revenue stood at -$7.3 million, which was down 48.24% from -$4.9 million recorded in Q1 2025.
  • Over the past 5 years, Abivax's Revenue peaked at $33,384 during Q2 2024, and registered a low of -$7.3 million during Q2 2025.
  • For the 3-year period, Abivax's Revenue averaged around -$3.0 million, with its median value being -$2.9 million (2025).
  • Per our database at Business Quant, Abivax's Revenue slumped by 687,768.93% in 2023 and then grew by 0.49% in 2025.
  • Over the past 4 years, Abivax's Revenue (Quarterly) stood at $4.69 in 2022, then tumbled by 687,768.93% to -$32,273 in 2023, then slumped by 2,611.74% to -$875,166 in 2024, then plummeted by 21,899.29% to -$7.3 million in 2025.
  • Its last three reported values are -$7.3 million in Q2 2025, -$4.9 million for Q1 2025, and -$875,166 during Q4 2024.